Andros Pharmaceuticals Co.,Ltd (6917.TWO)
TWD 16.35
(-2.39%)
TWD 16.35
(-2.39%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -61.5 Million TWD | -79.04% |
| 2022 | -34.34 Million TWD | -15.51% |
| 2021 | -29.73 Million TWD | -6.8% |
| 2020 | -27.84 Million TWD | 53.98% |
| 2019 | -60.5 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 FY | - TWD | -79.04% |
| 2022 FY | - TWD | -15.51% |
| 2021 FY | - TWD | -6.8% |
| 2020 FY | - TWD | 53.98% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 115.625% |
| Level Biotechnology Inc. | 98.7 Million TWD | 162.308% |
| Sagittarius Life Science Corp | -44.73 Million TWD | -37.464% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 14.72% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 57.201% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 40.646% |
| Visgeneer Inc. | 973 Thousand TWD | 6420.658% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 106.567% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 161.6% |
| Neith Corporation | -33.61 Million TWD | -82.981% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -3440.587% |
| Enimmune corporation | -228.96 Million TWD | 73.14% |
| TaiRx, Inc. | -208.64 Million TWD | 70.524% |
| EirGenix Inc. | -664.4 Million TWD | 90.744% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 183.216% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 188.946% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 23.194% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 45.626% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 276.531% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -133.84% |
| RBC Bioscience Corporation | 36.54 Million TWD | 268.276% |
| BiOptic Inc. | 65.03 Million TWD | 194.56% |
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -32.99% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -86.33% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -11.991% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 114.185% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 81.884% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 93.795% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 1.349% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -143.728% |
| GlycoNex Incorporation | -126.82 Million TWD | 51.509% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 381.981% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -246.948% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 94.26% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 90.988% |
| VBI | -6.97 Million TWD | -782.1% |
| CHO Pharma, Inc. | -277.73 Million TWD | 77.856% |
| NaviFUS Corp. | -55.79 Million TWD | -10.225% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -270.527% |
| Sinew Pharma Inc. | -163.63 Million TWD | 62.415% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 131.964% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 72.869% |
| AP Biosciences Inc | -325.51 Million TWD | 81.107% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 94.113% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -71.567% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 311.123% |
| Intech Biopharm Corporation | -219.58 Million TWD | 71.993% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 90.878% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -36.816% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 61.767% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 109.382% |
| TCI GENE Inc. | 25.98 Million TWD | 336.711% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 44.413% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 78.329% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 57.868% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 544.043% |
| PharmaEngine, Inc. | 347.3 Million TWD | 117.708% |
| Savior Lifetec Corporation | 219.6 Million TWD | 128.005% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 135.708% |
| OBI Pharma, Inc. | -855.08 Million TWD | 92.808% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 33.559% |
| Acepodia, Inc. | -764.51 Million TWD | 91.956% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 86.633% |